No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
002581 Shandong Sinobioway Biomedicine
- 10.42
- -0.22-2.07%
Not Open Jan 20 15:00 CST
6.87BMarket Cap-19.77P/E (TTM)
10.81High10.38Low57.44KlotVolume10.75Open10.64Pre Close60.67MTurnover1.43%Turnover RatioLossP/E (Static)659.74MShares14.4352wk High3.29P/B4.18BFloat Cap7.7952wk Low11.70Limit Up400.79MShs Float71.85Historical High9.58Limit Down4.04%Amplitude4.39Historical Low--Dividend TTM10.56Avg Price34.74KlotAsk--Div YieldTTM100Lot Size21.10KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Shandong Sinobioway Biomedicine (002581.SZ): plans to increase the capital of its wholly-owned subsidiary ShanDong YanDu by 0.29 billion yuan.
On January 3, Gelonghui reported that Shandong Sinobioway Biomedicine (002581.SZ) announced the company is using its own funds to increase capital by 0.29 billion yuan for its wholly-owned subsidiary ShanDong Yandu Biotechnology Co., Ltd. (referred to as "ShanDong Yandu"), of which 0.29 billion yuan will be included in registered capital and 0 yuan in capital surplus. After the capital increase, ShanDong Yandu's registered capital will reach 0.3 billion yuan, remaining a wholly-owned subsidiary of the company. Meanwhile, the Board of Directors has authorized the company's management to handle the specific procedures related to the capital increase.
Shandong Sinobioway Biomedicine (002581.SZ) subsidiary plans to hire Happy Life to provide clinical trial technical services.
Shandong Sinobioway Biomedicine (002581.SZ) announced that the company's Board of Directors has reviewed and approved the "Agreement on Signing the Technical..."
Express News | Shandong Sinobioway Biomedicine: Signed a technical service agreement for drug clinical trials worth 55.8176 million yuan.
Shandong Sinobioway Biomedicine (002581.SZ) has appointed **** as the financial director.
Shandong Sinobioway Biomedicine (002581.SZ) announced that the company's board of directors recently received a report from the Chief Financial Officer, Mr. Liu Yangjun...
Shandong Sinobioway Biomedicine (002581.SZ) plans to launch a stock options incentive plan for 2024, with an exercise price of 12.35 yuan per share.
Shandong sinobioway biomedicine (002581.SZ) announced the 2024 stock options incentive plan (draft), which grants...
Express News | Shandong Sinobioway Biomedicine plans to transfer 26.84% of its equity in subsidiary Yingkou Chemical for 74.0254 million yuan.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
